XML 67 R45.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Equity-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Summary of Compensation Cost Recognized

Presented below is a summary of the compensation cost recognized in the condensed consolidated statements of operations and comprehensive (loss) for the three months ended March 31, 2024 and 2023.

 

 

 

Three Months Ended March 31,

 

 

 

2024

 

 

2023

 

 

 

(in thousands)

 

Research and development

 

$

1,231

 

 

$

2,131

 

Sales and marketing

 

 

75

 

 

 

222

 

General and administrative

 

 

2,060

 

 

 

12,286

 

Total stock-based compensation expense

 

$

3,366

 

 

$

14,639

 

Summary of Stock Option Activity

The following summary sets forth the stock option activity under the 2023 and 2020 Plan:

 

 

Number of options

 

 

Weighted average exercise price

 

 

Weighted average remaining contractual term (in years)

 

 

Aggregate intrinsic value (in thousands)

 

Outstanding as of December 31, 2023

 

 

3,417,932

 

 

$

2.53

 

 

 

9.3

 

 

$

547

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

Cancelled or forfeited

 

 

(6,200

)

 

 

0.51

 

 

 

 

 

 

 

Outstanding as of March 31, 2024

 

 

3,411,732

 

 

$

2.53

 

 

 

9.0

 

 

$

 

Options exercisable as of March 31, 2024

 

 

1,139,304

 

 

$

1.64

 

 

 

8.8

 

 

$

 

Options unvested as of March 31,2024

 

 

2,463,196

 

 

$

3.16

 

 

 

9.1

 

 

$

 

Summary of Unvested Common Stock

A summary of unvested common stock from early option exercises that are subject to repurchase by the Company under the 2020 Plan is as follows:

 

 

Early Option Exercises

 

 

Number of options

 

 

Weighted average exercise price

 

 

Repurchase liability (in thousands)

 

Unvested common stock as of December 31, 2023

 

 

13,720

 

 

$

 

 

$

8

 

Issued

 

 

 

 

 

 

 

 

 

Vested

 

 

(3,272

)

 

 

 

 

 

 

Repurchased

 

 

 

 

 

 

 

 

 

Unvested common stock as of March 31, 2024

 

 

10,448

 

 

 

 

 

$

8

 

Summary of Stock Option Valuation Assumptions The fair value of each option was estimated at the grant date using the Black-Scholes method with the following assumptions:

 

 

 

March 31,

 

 

March 31,

 

 

2024

 

 

2023

 

Weighted-average risk-free interest rate (1)

 

 

%

 

 

3.6

%

Weighted-average expected term (in years)

 

 

 

 

 

6.03

 

Weighted-average expected volatility (2)

 

 

%

 

 

57.9

%

Expected dividend yield

 

 

%

 

 

%

 

(1)
Based on U.S. Treasury seven-year constant maturity interest rate whose term is consistent with the expected term of the option.
(2)
Expected volatility is based on an analysis of comparable public company volatilities and adjusted for the Company’s stage of development.